FDA approves dasatinib for children with Philadelphia chromosome-positive chronic myeloid leukemia

The FDA expanded the indication for dasatinib to include the treatment of children with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Tags:

2017
news
CML

To wipe childhood cancer off the map, scientists must chart its genomic landscape

Childhood Liver Cancer "Signatures" May Help Predict Response to Chemo

New chemical technology leads to better targeted therapeutics against high-risk leukemia in the lab

Hopes of a new curative treatment for children with neuroblastoma

Scientists are a step closer to finding a low toxicity treatment for childhood leukaemia

Researchers identify an Achilles’ heel in neuroblastoma

To save children with cancer, doctors turn to new weapons

Childhood Cancer Survivors Are at an Increased Risk for Hospitalization Years After Treatment Ends

Novel targeted therapy could be effective treatment option for deadly childhood cancer

Gene That Causes Deadliest Brain Tumor Also Causes Childhood Cancer

Recent Posts

FDA approves dasatinib for children with Philadelphia chromosome-positive chronic myeloid leukemia

Archive

Search By Tags